Rivastigmins hæmning af butyrylkolinesterase- aktivitet i CSF hos 14 patienter med Alzheimers var sammenlignelig med hæmningen af AChE.
Inhibition of butyrylcholinesterase activity in CSF of 14 Alzheimer patients treated by oral rivastigmine was similar to that of AChE.